Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment

NCT05484375 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Nasopharyngeal Carcinoma

Interventions

DRUG: Capecitabine plus toripalimab

Sponsor

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Collaborators

[object Object]
[object Object]